Relationship between Human T Lymphotropic Virus (HTLV) Type 1/2 Viral Burden and Clinical and Treatment Parameters among Patients with HIV Type 1 and HTLV-1/2 Coinfection | Zendy

Mark A. Beilke | Zendy; V. L. T. Dorge | Zendy; Maria J. Sirois | Zendy; A F M Anhar Uddin Bhuiyan | Zendy; Edward L. Murphy | Zendy; J. M. Walls | Zendy; Ryan Fagan | Zendy; E. L. Winsor | Zendy; Patricia Kissinger | Zendy

Open Access

Relationship between Human T Lymphotropic Virus (HTLV) Type 1/2 Viral Burden and Clinical and Treatment Parameters among Patients with HIV Type 1 and HTLV-1/2 Coinfection

Author(s) -

Mark A. Beilke,

V. L. T. Dorge,

Maria J. Sirois,

A F M Anhar Uddin Bhuiyan,

Edward L. Murphy,

J. M. Walls,

Ryan Fagan,

E. L. Winsor,

Patricia Kissinger

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/513428

Subject(s) - coinfection , medicine , virology , viral load , human t lymphotropic virus 1 , virus , peripheral blood mononuclear cell , immunology , human t lymphotropic virus , biology , t cell leukemia , biochemistry , myelopathy , psychiatry , spinal cord , in vitro

Human T lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) are frequent copathogens among individuals infected with human immunodeficiency virus type 1 (HIV-1). The long-term effects of coinfection are unknown, and little information exists regarding how levels of HTLV-1/2 viral burden are affected by antiretroviral medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research